Have a personal or library account? Click to login
Use of PPV (23G) in a 55-year-old patient with high myopia 23 days after phacoemulsification complicated by suprachoroidal hemorrhage Cover

Use of PPV (23G) in a 55-year-old patient with high myopia 23 days after phacoemulsification complicated by suprachoroidal hemorrhage

Open Access
|May 2025

References

  1. Lavinsky F, Moisseiev J, Levkovitch-Verbin H. The surgical management of massive intraoperative and postoperative suprachoroidal hemorrhage: anatomic and functional outcomes. Arq Bras Oftalmol. 2013; 76: 212–4.
  2. Speaker MG, Guerriero PN, Met JA, Coad CT, Berger A, Marmor M. A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage. Ophthalmol. 1991; 98: 202–9.
  3. Eriksson A, Koranyi G, Seregard S, Philipson B. Risk of acute suprachoroidal hemorrhage with phacoemulsification. J Cataract Refract Surg. 1998; 24(6): 793–800.
  4. Ling R. Suprachoroidal haemorrhage complicating cataract surgery in the UK: epidemiology, clinical features, management, and outcomes. Br J Ophthalmol. 2004; 88: 478–80.
  5. Spaeth GL, Danesh-Meyer HV, Goldberg I, Kmapik A. Ophtlamic Surgery Principles and Practice, 4th ed.; 2012: 92–93.
  6. Flores Márquez A, Urbinati F, Rocha-de-Lossada C, Moreno Gutiérrez JÁ, Munteanu M, Ferrara M, Fernández J. Management of Suprachoroidal Hemorrhage during Phacoemulsification: A Comprehensive Review. Medicina (Kaunas). 2023; 59: 583.
  7. Qureshi A, Jalil A, Sousa DC, Patton N, Dhawahir-Scala F, Charles SJ, Turner G, Ivanova T. Outcomes of suprachoroidal haemorrhage drainage with and without vitrectomy: a 10-year study. Eye (Lond). 2021; 35: 1879–85.
  8. Lakhanpal V. Experimental and clinical observations on massive suprachoroidal hemorrhage. Trans Am Ophthalmol Soc. 1993; 91: 545–652.
  9. Laube T, Brockmann C, Bornfeld N. Massive suprachoroidal hemorrhage: Surgical management and outcome. GMS Ophthalmol Cases. 2015; 5.
  10. Meier P, Wiedemann P. Massive suprachoroidal hemorrhage: secondary treatment and outcome. Graefes Arch Clin Exp Ophthalmol. 2000; 238: 28–32.
  11. Scott IU, Flynn HW Jr, Schiffman J, Smiddy WE, Murray TG, Ehlies F. Visual acuity outcomes among patients with appositional suprachoroidal hemorrhage. Ophthalmol. 1997; 104(12): 2039–46.
  12. Lavinsky F, Moisseiev J, Levkovitch-Verbin H. The surgical management of massive intraoperative and postoperative suprachoroidal hemorrhage: anatomic and functional outcomes. Arq Bras Oftalmol. 2013; 76: 212–4.
  13. Stankiewicz A, Ustymowicz A, Zalewska R, Tarasów E, Krejza J. Dopplerowska ocena parametrów przepływu krwi w naczyniach oczodołu u chorych z podwyższonym ciśnieniem wewnątrzgałkowym. Okulistyka. Numer specjalny – czerwiec’ 99. 1999: 3–5.
  14. Beatty S, Lotery A, Kent D, O’Driscoll A, Kilmartin DJ, Wallace D, Baglivo E. Acute suprachoroidal haemorrhage in ocular surgery. Eye (Lond). 1998; 12: 815–20.
  15. Chak M, Williamson T. Spontaneous suprachoroidal haemorrhage associated with high myopia and aspirin. Eye (Lond). 2003; 17: 525–7.
  16. Fung YC. Biomechanics: Mechanical Properties of Living Tissues, 2nd ed.; New York: Springer-Verlag; 1993.
  17. Kuhn F, Morris R, Mester V. Choroidal detachment and expulsive choroidal hemorrhage. Ophthalmol Clin North Am. 2001; 14: 639–50.
  18. Reynolds MG, Haimovici R, Flynn HW, DiBernardo C, Byrne SF, Feuer W. Suprachoroidal hemorrhage. Clinical features and results of secondary surgical management. Ophthalmol. 1993; 100: 460–5.
  19. Salomon O, Huna-Baron R, Steinberg DM, Kurtz S, Seligsohn U. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 1999; 13: 357–9.
Language: English
Page range: 70 - 75
Submitted on: Dec 16, 2024
|
Accepted on: Apr 2, 2025
|
Published on: May 28, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Dawid Woszczek, Sebastian Sirek, Tomasz Wilczyński, Dorota Wyględowska-Promieńska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.